31st Annual ROTH Conference
March 17-20, 2019
Ritz Carlton, Dana Point, CA
ROTH Capital Partners' 31st Annual Conference is one of the largest of its kind in the United States. With roughly 550 participating companies and over 4,700 attendees, Roth will feature presentations from hundreds of public and private companies in a variety of sectors including health care; technology, Internet and media; cleantech, industrial growth and solar; consumer; oil and gas/mining and minerals; and business services. The three-and-a-half day event will include company presentations and small group meetings, as well as panels, entertainment and more. This gathering of institutional investors, private equity investors, VCs, company executives and service providers has become a must attend event for anyone working in the small and mid-cap space. For more information visit www.Roth.com
22nd Century Group Inc. (XXII)
22nd Century Group (NYSE: XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company's primary mission in tobacco is to reduce the harm caused by smoking. The company's primary mission in hemp/cannabis is to develop proprietary hemp strains for important new medicines and agricultural crops. For more information, visit the company's website at www.xxiicentury.com.
A-Mark Precious Metals Inc. (AMRK)
A-Mark Precious Metals (NASDAQ: AMRK) is a full-service precious metals trading company and wholesaler of gold, silver, platinum and palladium bullion and related products. The company's global customer base includes sovereign and private mints, manufacturers and fabricators, refiners, dealers and online retailers, financial institutions, industrial users, investors, collectors and retail customers. The company conducts its operations through three complementary segments: Wholesale Trading & Ancillary Services, Secured Lending and Direct Sales. A-Mark is headquartered in El Segundo, California, and with offices and facilities in Vienna, Austria, and Las Vegas, Nevada. For more information, visit the company's website at www.amark.com.
Abraxas Petroleum Corp. (AXAS)
Abraxas Petroleum (NASDAQ: AXAS) is an independent exploration and production company founded in 1977 and based in San Antonio, Texas. Abraxas focuses primarily on the development of conventional and unconventional resources in its primary operating areas in the Rocky Mountains, South Texas, Powder River Basin and Permian Basin. Abraxas' business model focuses on assets with: high working interest, operational and infrastructure control, low geologic risk, strong full cycle ROR, low risk exploitable upside using the company's proven operating expertise. For more information, visit the company's website at www.abraxaspetroleum.com.
Acer Therapeutics Inc. (ACER)
Acer Therapeutics (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with critical unmet medical need. Acer's pipeline now includes three clinical-stage candidates. Acer's product candidates are de-risked, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and an accelerated path for development which may expedite the preparation, submission and approval of a marketing application. For more information, visit the company's website at www.acertx.com.
ACM Research Inc. (ACMR)
ACM Research (NASDAQ: ACMR) develops wet processing technology and products for the semiconductor industry. The company has produced equipment for a range of applications in IC manufacturing and wafer level packaging — with a special focus on cleaning technologies for advanced semiconductor devices. ACM's Smart Megasonix technologies enable a more thorough megasonic wafer cleaning and at the same time, a much gentler cleaning than previous technologies delivering higher yields and increased profits. For more information, visit the company's website at www.acmrcsh.com.
Acme United Corp. (ACU)
Acme United (NYSE: ACU) is a worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware and industrial markets. The company's operations are in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). Acme United aims to be the leading supplier of cutting, measuring and safety products to businesses, schools and homes worldwide; to be known for quality and innovation in all the categories in which it participates; and to enter new categories with innovation that surpasses the competition. For more information, visit the company's website at www.acmeunited.com.
Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) is the largest vertically integrated, multi-state owner of cannabis licenses and assets in U.S. states, with respect to number of states with operating licenses. With operating licenses in 19 states, serving a population of more than 172 million Americans, and an estimated 2022 total addressable market of approximately $14 billion in legal cannabis sales according to Arcview Market Research. Acreage is dedicated to building and scaling operations to create a seamless, consumer-focused branded cannabis experience. For more information, visit the company's website at www.acreageholdings.com.
Actinium Pharmaceuticals Inc. (ATNM)
Actinium Pharmaceuticals (NYSE: ATNM), with its proprietary, chemotherapy free or sparing, targeted conditioning technology, is focused on improving patient access and outcomes to cellular therapies such as bone marrow transplant (BMT) and CAR-T. Actinium is the only company with a multi-disease, multi-target, drug development pipeline focused on targeted conditioning. Its targeted conditioning technology is enabled by ARC's or Antibody Radiation Conjugates that combine the targeting ability of monoclonal antibodies with the cell killing ability of radioisotopes. For more information, visit the company's website at www.actiniumpharma.com.
Adesto Technologies Corp. (IOTS)
Adesto Technologies (NASDAQ: IOTS) is a provider of innovative application-specific semiconductors and embedded systems for the Internet of Things (IoT) era. The company's technology is used by more than 2,000 global customers who are creating differentiated solutions across industrial, consumer, medical and communications markets. With its growing portfolio of high-value technologies, Adesto is helping its customers usher in the era of the IoT. For more information, visit the company's website at www.adestotech.com.
ADOMANI Inc. (ADOM)
ADOMANI (NASDAQ: ADOM) is a provider of zero-emission electric and hybrid drivetrain systems for integration in new school buses and medium to heavy-duty commercial fleet vehicles, as well as providing patented conversion kits to replace drivetrain systems for combustion-powered vehicles. ADOMANI is focused on reducing the total cost of vehicle ownership and helps fleet operators unlock the benefits of green technology and address the challenges of traditional fuel price cost instability and local, state and federal environmental regulatory compliance. For more information, visit the company's website at www.ADOMANIelectric.com.
Advanced Energy Industries (AEIS)
Advanced Energy Industries (NASDAQ: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE's power solutions enable customer innovation in complex semiconductor and industrial manufacturing applications. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers. For more information, visit the company's website at www.advancedenergy.com.
Agile Therapeutics Inc. (AGRX)
Agile Therapeutics (NASDAQ: AGRX) is a women's healthcare company dedicated to fulfilling the unmet health needs of today's women. The company's product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Agile's lead product candidate, Twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. Twirla is based on Agile's proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com.
Agilysys Inc. (AGYS)
Agilysys (NASDAQ: AGYS) is a technology company that provides innovative software and services for point-of-sale (POS), property management (PMS), reservation and table management, inventory and procurement, workforce management, analytics, document management, and mobile and wireless solutions exclusively to the hospitality industry. The company's products and services allow operators to streamline operations, improve efficiency and understand customer needs across their properties to deliver a superior overall guest experience. Agilysys serves four major market sectors: gaming, both corporate and tribal; hotels, resorts and cruise; corporate foodservice management; and restaurants, universities, stadia and healthcare. For more information, visit the company's website at www.agilysys.com.
AgroFresh Solutions Inc. (AGFS)
AgroFresh Solutions (NASDAQ: AGFS) is a global provider of innovative food preservation and waste reduction solutions for fresh produce. The company is empowering the food industry with Smarter Freshness, a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality, reducing waste. AgroFresh's solutions range from pre-harvest with Harvista and LandSpring to its marquis SmartFresh Quality System. AgroFresh has key products registered in over 45 countries, with approximately 3,000 direct customers and services over 25,000 storage rooms globally. For more information, visit the company's website at www.agrofresh.com.
Aimmune Therapeutics Inc. (AIMT)
Aimmune Therapeutics (NASDAQ: AIMT) is a biopharmaceutical company developing oral treatments for life-threatening food allergies. The company's Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune intends to submit a regulatory filing for marketing approval of its first investigational biologic product, AR101, in Europe during the first half of 2019 based on data from Aimmune's pivotal phase 3 PALISADE clinical trial of AR101. For more information, visit the company's website at www.aimmune.com.
Airgain Inc. (AIRG)
Airgain (NASDAQ: AIRG) is a provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including connected home, enterprise, automotive, and Internet of Things (IoT). Combining design-led thinking with testing and development, Airgain works in partnership with the entire ecosystem, including carriers, chipset suppliers, OEMs and ODMs. Airgain's antennas are deployed in carrier, fleet, enterprise, residential, private, government and public safety wireless networks and systems, including set-top boxes, access points, routers, modems, gateways, media adapters, portables, digital televisions, sensors, fleet and asset tracking devices. For more information, visit the company's website at www.airgain.com.
AIT Therapeutics Inc. (AITB)
AIT Therapeutics (OTC: AITB) is a clinical-stage medical device and biopharmaceutical company using nitric oxide (NO) to treat respiratory and other diseases. The company is currently applying its therapeutic expertise to treat lower respiratory tract infections that are not effectively addressed with current standards of care, as well as pulmonary hypertension, in various settings. AIT Therapeutics is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and nontuberculous mycobacteria (NTM). For more information, visit the company's website at www.AIT-Pharm.com.
Akoustis Technologies Inc. (AKTS)
Akoustis Technologies (NASDAQ: AKTS) is a high-tech BAW RF filter solutions company pioneering next-generation materials science and MEMS wafer manufacturing to address market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The company utilizes its proprietary XBAW manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. For more information, visit the company's website at www.akoustis.com.
Alarm.com Holdings Inc. (ALRM)
Alarm.com Holdings (NASDAQ: ALRM) is a platform for the intelligently connected property. Millions of people use Alarm.com's technology to monitor and control their property from anywhere. Centered on security and remote monitoring, the company's platform addresses a wide range of market needs and enables application-based control for a growing variety of Internet of Things (IoT) devices. Alarm.com's security, video monitoring, intelligent automation, energy management and wellness solutions are available through its network of thousands of professional service providers in North America and around the globe. For more information, visit the company's website at www.alarm.com.
Albireo Pharma Inc. (ALBO)
Albireo Pharma (NASDAQ: ALBO) is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo's lead product candidate, A4250, is being developed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication. Albireo's clinical pipeline also includes two phase 2 product candidates. Albireo's elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was spun out from AstraZeneca in 2008. For more information, visit the company's website at www.albireopharma.com.
Aleafia Health (TSXV: ALEF) (OTC: ALEAF) (FRA: ARAH) is a vertically integrated, national cannabis health and wellness company with major medical clinic, cannabis cultivation and R&D operations. The company is a federally licensed producer and vendor of cannabis and will reach an annual production capacity of 98,000 kg of dried cannabis in 2019. Aleafia operates medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The company is highly differentiated, maintaining one of the largest medical cannabis datasets in the world. For more information, visit the company's website at www.aleafiainc.com.
Alexco Resource Corp. (AXU)
Alexco Resource (NYSE: AXU) owns the majority of the high-grade Keno Hill Silver District in Canada's Yukon Territory and anticipates the sequential development of four high grade silver deposits over an eight-year mine life producing more than 1 million tons with an average grade of 843 g/t silver, 3.3% lead and 4.6% zinc. Silver production is anticipated to be approximately 3.5 million ounces per year. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Alexco also operates a wholly owned subsidiary, Alexco Environmental Group, that provides mine-related environmental services, remediation technologies and reclamation and mine closure services. For more information, visit the company's website at www.alexcoresource.com.
Allena Pharmaceuticals Inc. (ALNA)
Allena Pharmaceuticals (NASDAQ: ALNA) is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. For more information, visit the company's website at www.allenapharma.com.
Allied ESports Entertainment (AESE)
Allied ESports Entertainment (OTC: AESE) is an esports entertainment company dedicated to providing world-class in-person experiences, multiplatform content and interactive services to the global video gaming community. Black Ridge Acquisition Corp. has entered into a definitive agreement whereby Black Ridge will acquire Allied Esports and WPT Enterprises, Inc. The combined company will be renamed Allied Esports Entertainment, Inc. and is expected to trade on the NASDAQ Capital Market. By combining Allied Esports' global network of properties and content creation facilities with WPT's nearly 20 years of international expertise in live events, content distribution and customer engagement, AESE will provide esports audiences with offerings unparalleled in the industry today. For more information, visit the company's website at www.alliedesports.gg.
Allied Motion Technologies Inc. (AMOT)
Allied Motion Technologies (NASDAQ: AMOT) designs, manufactures and sells precision and specialty motion control components and systems used in a broad range of industries within major markets, including vehicle, medical, aerospace & defense, and industrial. Allied Motion is focused on motion control applications and is known worldwide for its expertise in electro-magnetic, mechanical and electronic motion technology. Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, and other associated motion control-related products. For more information, visit the company's website at www.alliedmotion.com.
Altimmune Inc. (ALT)
Altimmune (NASDAQ: ALT) is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company strategically employs two distinct and complementary immune platform technologies to create innovative candidates for important diseases. By leveraging the complementary attributes of its proprietary technology platforms, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including both acute and chronic infections and cancer. For more information, visit the company's website at www.altimmune.com.
Aly Energy Services Inc. (ALYE)
Aly Energy Services (OTC: ALYE) and its subsidiaries provide equipment and services essential to the drilling and development of oil and gas resources, including mud delivery, solids control, fluid management, and directional drilling and measurement-while-drilling services. The company serves the Permian Basin (in Texas and New Mexico), Eagle Ford Shale, Utica Shale, Marcellus Shale, Woodford Shale, Granite Wash, Mississippian Lime, and Tuscaloosa Marine Shale. For more information, visit the company's website at www.alyenergy.com.
Ambarella Inc. (AMBA)
Ambarella (NASDAQ: AMBA) develops products that are used in a wide variety of human and computer vision applications, including surveillance, Advanced Driver Assistance Systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and robotic applications. Ambarella's low-power and high-resolution video compression, image processing, and deep neural network processors and software enable cameras to become more intelligent by extracting valuable data from high-resolution video streams. For more information, visit the company's website at www.ambarella.com.
Ameresco Inc. (AMRC)
Ameresco (NYSE: AMRC) is an independent provider of comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations throughout North America and Europe. Ameresco's sustainability services include upgrades to a facility's energy infrastructure and the development, construction and operation of renewable energy plants. Ameresco has successfully completed energy saving, environmentally responsible projects with federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. For more information, visit the company's website at www.ameresco.com.
American Outdoor Brands Corp. (AOBC)
American Outdoor Brands (NASDAQ: AOBC) is a provider of quality products for shooting, hunting and rugged outdoor enthusiasts in the global consumer and professional markets. The company reports two segments: Firearms and Outdoor Products & Accessories. Firearms manufactures handgun and long gun products sold under the Smith & Wesson, Performance Center, M&P, Thompson/Center Arms, and Gemtech brands as well as provides forging, machining, and precision plastic injection molding services. Outdoor Products & Accessories provides shooting, hunting, and outdoor accessories, including reloading, gunsmithing, and gun cleaning supplies, tree saws, knives, laser sighting systems, tactical lighting products, and survival and camping equipment. For more information, visit the company's website at www.aob.com.
American Vanguard Corp. (AVD)
American Vanguard (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor's Small Cap 600 Index. For more information, visit the company's website at www.american-vanguard.com.
Americas Silver Corp. (USAS)
Americas Silver (NYSE: USAS) is a silver mining company focused on growth in precious metals from its existing asset base and execution of targeted accretive acquisitions. It owns and operates the Cosalá Operations in Sinaloa, Mexico, and the Galena Complex in Idaho, USA. The company holds an option on the San Felipe development project in Sonora, Mexico. For more information, visit the company's website at www.americassilvercorp.com.
Amerigo Resources Ltd. TSX: ARG) (OTC: ARREF) is an innovative copper producer with a long-term relationship with Corporación Nacional del Cobre de Chile ("Codelco"), the world's largest copper producer. Amerigo produces copper concentrate at the MVC operation in Chile by processing fresh and historic tailings from Codelco's El Teniente mine, the world's largest underground copper mine. For more information, visit the company's website at www.amerigoresources.com.
Amira Nature Foods Ltd. (ANFI)
Amira Nature Foods Ltd. (NYSE: ANFI), founded in 1915, has evolved into a global provider of packaged specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under its flagship Amira brand as well as under other third-party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira's headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States. For more information, visit the company's website at www.amira.net.
AMSC (NASDAQ: AMSC) generates the ideas, technologies and solutions that meet the world's demand for smarter, cleaner and better energy. Through its Windtec Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. Through its Gridtec Solutions, AMSC provides engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. AMSC's solutions are now powering gigawatts of renewable energy globally and are enhancing the performance and reliability of power networks in more than a dozen countries. For more information, visit the company's website at www.amsc.com.
Amtech Systems Inc. (ASYS)
Amtech Systems (NASDAQ: ASYS) is a global supplier of advanced thermal processing and polishing equipment and related consumables to the semiconductor/electronics, power IC businesses, solar and advanced lighting manufacturing markets. Amtech's equipment includes diffusion, solder reflow systems, wafer handling automation, ALD and PECVD systems and polishing equipment and related consumables for surface preparation of various materials, including silicon carbide, sapphire and silicon. The company's products currently address the diffusion, oxidation, and deposition steps used in the fabrication of semiconductors, printed circuit boards, semiconductor packaging, solar cells, MEMS and advanced lighting, including the polishing of newly sliced sapphire and silicon wafers. For more information, visit the company's website at www.amtechsystems.com.
Amyris Inc. (AMRS)
Amyris (NASDAQ: AMRS) is an integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering it's No Compromise products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. For more information, visit the company's website at www.Amyris.com.
Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences (NASDAQ: AVXL) is a biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system diseases, pain and various types of cancer. Anavex's lead drug candidate, ANAVEX 2-73, recently completed a successful phase 2a clinical trial for Alzheimer's disease. ANAVEX 2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer's disease. For more information, visit the company's website at www.anavex.com.
Aphria (TSX: APHA) (NYSE: APHA) is a global cannabis company known for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents. For more information, visit the company's website at www.aphria.ca.
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics (NASDAQ: APVO) is a clinical-stage biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients' lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer or autoimmune diseases. Aptevo has a broad pipeline of novel investigational-stage bispecific antibody candidates focused in immuno-oncology and autoimmune disease and inflammation. For more information, visit the company's website at www.aptevotherapeutics.com.
Aptose Biosciences Inc. (APTO)
Aptose Biosciences (NASDAQ: APTO) is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. APTO-253, the only known clinical stage agent that directly targets the MYC oncogene and inhibits its expression, is in a phase 1b clinical trial for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or high risk MDS. For more information, visit the company's website at www.aptose.com.
Aquantia Corp. (AQ)
Aquantia (NYSE: AQ) designs, develops and markets advanced, high-speed communications ICs for Ethernet connectivity in the Data Center, Enterprise Infrastructure, Access and Automotive markets. Aquantia products are designed to cost-effectively deliver leading-edge data speeds for use in the latest generation of communications infrastructure to alleviate network bandwidth bottlenecks caused by the growth of global IP traffic. For more information, visit the company's website at www.aquantia.com.
AquaVenture (NYSE: WAAS) is a multinational provider of WAAS solutions that provide customers a reliable and cost-effective source of clean drinking and process water primarily under long-term contracts that minimize capital investment by the customer. AquaVenture is composed of two operating platforms: Quench, a leading provider of filtered water systems and related services with over 140,000 units installed at institutional and commercial customer locations across the U.S. and Canada; and Seven Seas Water, a multinational provider of desalination and wastewater treatment solutions, providing more than 8.5 billion gallons of potable, high purity industrial grade and ultra-pure water per year to governmental, municipal, industrial and hospitality customers. For more information, visit the company's website at www.aquaventure.com.
Arch Therapeutics Inc. (ARTH)
Arch Therapeutics (OTC: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include AC5™ Topical Gel, AC5™ Topical Hemostat1 and AC5™ Surgical Hemostat1. For more information, visit the company's website at www.archtherapeutics.com.
Arcimoto Inc. (FUV)
Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that together raise the bar for environmental efficiency, footprint and affordability. Arcimoto is the maker of the Fun Utility Vehicle® (FUV) — an affordable, joyful, pure electric vehicle for everyday drivers and fleets. Available for pre-order today, Arcimoto has branded its FUV as one of the lightest, most affordable, and most appropriate electric vehicles suitable for the daily driver. For more information, visit the company's website at www.arcimoto.com.
Arcturus Therapeutics Ltd. (ARCT)
Arcturus Therapeutics (NASDAQ: ARCT) is an RNA medicines company with enabling technologies – UNA Oligomer chemistry and LUNAR lipid-mediated delivery. Arcturus' diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis, and vaccines. Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. Arcturus' proprietary UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes. For more information, visit the company's website at www.Arcturusrx.com.
ArQule Inc. (ARQL)
ArQule (NASDAQ: ARQL) is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. ArQule's mission is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve patient's lives. The company's clinical-stage pipeline consists of five drug candidates, all of which are in targeted, biomarker-defined patient populations. ArQule's current discovery efforts are focused on the identification and development of novel kinase inhibitors, leveraging the company's proprietary library of compounds. For more information, visit the company's website at www.arqule.com.
ASGN Inc. (ASGN)
ASGN (NYSE: ASGN) is one of the foremost providers of IT and professional services in the technology, digital, creative, healthcare technology, engineering, life sciences, and government sectors. ASGN and its divisions are viewed as best in class across multiple industries and have built an outstanding reputation for excellence over the past 33 years. ASGN is based in Calabasas, California, with multiple offices throughout the United States, Canada and Europe. For more information, visit the company's website at www.asgn.com.
Aspen Group Inc. (ASPU)
Aspen Group (NASDAQ: ASPU) is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. For more information, visit the company's website at www.aspu.com.
Assertio Therapeutics Inc. (ASRT)
Assertio Therapeutics (NASDAQ: ASRT) is committed to providing responsible solutions to advance patient care in the company's core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. For more information, visit the company's website at www.assertiotx.com.
Assure Holdings Corp. (ARHH)
Assure Holdings (OTC: ARHH) is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company's website at www.assureneuromonitoring.com.
Astea International Inc. (ATEA)
Astea International (OTC: ATEA) is a global player in field service and mobile workforce management, including the cornerstones of full-service lifecycle management: customer management, service management, asset management, forward and reverse logistics management, and mobile workforce management and optimization. Astea helps the world's best service-driven companies generate higher profit while balancing customer satisfaction and service levels through proactive communication that creates seamless, consistent and highly personalized experience at every customer relationship touch point. Astea's solutions unify processes, people, parts and information to focus the entire organization on the creation of sustainable value in highly competitive, global markets. For more information, visit the company's website at www.astea.com.
Asure Software Inc. (ASUR)
Asure Software (NASDAQ: ASUR) offers intuitive and innovative solutions designed to help organizations of all sizes and complexities build companies of the future. The company's cloud platforms enable more than 100,000 clients worldwide to better manage their people and space in a mobile, digital, multi-generational, and global workplace. Asure Software's offerings include a fully-integrated HCM platform, flexible benefits and compliance administration, HR consulting, and time and labor management as well as a full suite of workspace management solutions for conference room scheduling, desk sharing programs, and real estate optimization. For more information, visit the company's website at www.asuresoftware.com.
ASV Holdings Inc. (ASV)
ASV Holdings (NASDAQ: ASV) is a designer and manufacturer of compact construction equipment with emphasis on compact track loaders. Equipment designed and built by ASV uses unique and patented rubber track undercarriage technology that provides exceptional traction on soft, wet, slippery, rough or hilly terrain. For more information, visit the company's website at www.asvi.com.
Atomera Inc. (ATOM)
Atomera (NASDAQ: ATOM) has developed Mears Silicon Technology (MST), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies in the semiconductor industry roadmap. For more information, visit the company's website at www.atomera.com.
Attunity Ltd. (ATTU)
Attunity (NASDAQ: ATTU) provides data integration and big data management software solutions that enable availability, delivery and management of data across heterogeneous enterprise platforms, organizations and the cloud. The company's software solutions include data replication and distribution, test data management, change data capture (CDC), data connectivity, enterprise file replication (EFR), managed file transfer (MFT), data warehouse automation, data usage analytics and cloud data delivery. Attunity has supplied innovative software solutions to its enterprise-class customers for over 20 years and has successful deployments at thousands of organizations worldwide. For more information, visit the company's website at www.attunity.com.
aTyr Pharma Inc. (LIFE)
aTyr Pharma (NASDAQ: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr's research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes. aTyr is focused on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase gene family. For more information, visit the company's website at www.atyrpharma.com.
Auryn Resources Inc. (AUG)
Auryn Resources (NYSE: AUG) is a technically driven junior mining exploration company focused on delivering shareholder value through project acquisition and development. The company's management team is highly experienced with an impressive track record of success and has assembled an extensive technical team as well as a premier gold exploration portfolio. Auryn is focused on scalable high-grade gold deposits in established mining jurisdictions, which include the Committee Bay and Gibson MacQuoid gold projects located in Nunavut, the Homestake Ridge gold project in British Columbia and a portfolio of gold projects in southern Peru, through Corisur Peru SAC. For more information, visit the company's website at www.aurynresources.com.
Avalon GloboCare Corp. (AVCO)
Avalon GloboCare (NASDAQ: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to advancing cell-based technologies and therapeutics, with a focus on developing and empowering innovative and transformative cell-based technologies and their clinical applications. In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics, cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine. For more information, visit the company's website at www.avalon-globocare.com.
AxoGen Inc. (AXGN)
AxoGen (NASDAQ: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The company is helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. AxoGen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. AxoGen also offers AcroVal Neurosensory & Motor Testing System and AxoTouch Two-Point Discriminator, evaluation and measurement tools that assist health care professionals in nerve function assessment. For more information, visit the company's website at www.axogeninc.com.
AzurRx BioPharma Inc. (AZRX)
AzurRx BioPharma (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company's lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. For more information, visit the company's website at www.azurrx.com.
Ballard Power Systems Inc. (BLDP)
Ballard Power Systems (NASDAQ: BLDP) provides clean energy products that reduce customer costs and risks, and helps customers solve difficult technical and business challenges in their fuel cell programs. Ballard Power's vision is to be the leading global provider of innovative clean energy solutions offering superior performance at a reduced operating cost. For more information, visit the company's website at www.ballard.com.
Barrett Business Services Inc. (BBSI)
Barrett Business Services (NASDAQ: BBSI) is a provider of business management solutions, combining human resource outsourcing and professional management consulting to create a unique operational platform that differentiates it from competitors. The company's integrated platform is built upon expertise in payroll processing, employee benefits, workers' compensation coverage, risk management and workplace safety programs, and human resource administration. BBSI's partnerships help businesses of all sizes improve the efficiency of their operations. The company works with more than 5,600 clients across all lines of business in 24 states. For more information, visit the company's website at www.barrettbusiness.com.
BG Staffing Inc. (BGSF)
BG Staffing (NYSE: BGSF) through its various divisions provides staffing services to a range of industries. BG Staffing is primarily a professional temporary staffing platform that has integrated several regional and national brands achieving scalable growth. The company's disciplined acquisition philosophy, which builds value through both financial growth and the retention of unique and dedicated talent within BG Staffing's portfolio of companies, has resulted in a seasoned management team with strong tenure and the ability to offer exceptional service to candidates and customers while building value for investors. For more information, visit the company's website at www.bgstaffing.com.
BioCorRx Inc. (BICX)
BioCorRx (OTC: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components, first is an outpatient implant procedure that delivers naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component is a Cognitive Behavioral Therapy (CBT) program tailored specifically for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information, visit the company's website at www.BioCorRx.com.
BioDelivery Sciences International Inc. (BDSI)
BioDelivery Sciences International (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, and opioid dependence. For more information, visit the company's website at www.bdsi.com.
Biohitech (NASDAQ: BHTG) is changing the way people think about managing waste. The company's innovative waste management services combined with its disruptive technologies provide sustainable waste disposal and supply chain management solutions for businesses and municipalities of all sizes. Biohitech's cost-effective technology platforms can virtually eliminate landfill usage through real-time data analytics to reduce waste generation, biological disposal of food waste at the point of generation, and the processing of municipal solid waste into a valuable renewable fuel. For more information, please visit www.biohitech.com.
BioLife Solutions Inc. (BLFS)
BioLife Solutions (NASDAQ: BLFS) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. For more information, visit the company's website at www.biolifesolutions.com.
Biomerica Inc. (BMR)
Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care and in hospital/clinical laboratories for the early detection of medical conditions and diseases. Biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. The Biomerica InFoods IBS patent-pending product identifies specific foods that when removed may alleviate an individual's IBS symptoms. The point-of-care product is being developed to allow physicians to perform tests in-office using a finger stick blood sample. For more information, visit the company's website at www.biomerica.com.
Bionano Genomics Inc. (BNGO)
Bionano Genomics (NASDAQ: BNGO) is a life sciences instrumentation company in the genome analysis space. Bionano develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools. For more information, visit the company's website at www.bionanogenomics.com.
BioPharmX Corp. (BPMX)
BioPharmX (NYSE: BPMX) is a specialty pharmaceutical company focused on the dermatology market. The company's focus is to develop products that treat chronic dermatologic conditions that are not being adequately addressed or those where current therapies and approaches are suboptimal by developing prescription products through the company's proprietary HyantX Topical Delivery System for dermatology indications. For more information, visit the company's website at www.BioPharmX.com.
BioSig Technologies Inc. (BSGM)
BioSig Technologies (NASDAQ: BSGM) is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. BioSig Technologies is preparing to commercialize its PURE EP System, a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision-making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig's main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. For more information, visit the company's website at www.biosigtech.com.
BlackRidge Technology (BRTI)
BlackRidge Technology (OTC: BRTI) provides an adaptive cyber defense solution that enables customers to deliver more secure and resilient business services in today's rapidly evolving technology and cyberthreat environments. The BlackRidge Adaptive Trust solution provides end-to-end security that proactively isolates cloud services, protects servers and segments networks. The company's patented First Packet Authentication technology authenticates user and device identity and enforces security policy on the first packet of a network session. This new level of real-time protection blocks or redirects unidentified and unauthorized traffic to stop attacks and unauthorized access. For more information, visit the company's website at www.blackridge.us.
Blink Charging Co. (BLNK)
Blink Charging's (NASDAQ: BLNK) nationwide public electric vehicle (EV) charging equipment and services enable EV drivers to easily charge at locations throughout the United States. Blink Charging offers EV charging equipment and connectivity to the Blink Network, a cloud-based software that operates, manages and tracks the Blink EV charging stations and all the associated data. Blink Charging also owns and operates EV charging equipment predominately under the Blink brand. Blink Charging has strategic property partners across multiple business sectors including multifamily residential and commercial properties, airports, colleges, municipalities, parking garages, shopping malls, retail parking, schools and workplaces. For more information, visit the company's website at www.BlinkCharging.com.
Blue Bird Corp. (BLBD)
Blue Bird (NASDAQ: BLBD) is an independent designer and manufacturer of school buses, with more than 550,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird's longevity and reputation in the school bus industry have made it an iconic American brand. Blue Bird distinguishes itself from its principal competitors by its singular focus on the design, engineering, manufacture and sale of school buses and related parts. As the only manufacturer of chassis and body production specifically designed for school bus applications, Blue Bird is recognized as an industry leader for school bus innovation, safety, product quality/reliability/durability, operating costs and drivability. For more information, visit the company's website at www.blue-bird.com.
Borqs Technologies Inc. (BRQS)
Borqs Technologies Inc. (NASDAQ: BRQS) is a global leader in software and products for IoT providing customizable, differentiated and scalable Android-based smart connected devices and cloud service solutions. Borqs has achieved leadership and customer recognition as an innovative end-to-end IoT solutions provider leveraging its strategic chipset partner relationships as well as its broad software and IP portfolio. Borqs designs, develops and provides turnkey solutions across device form factors such as smartphones, tablets, smartwatches, trackers, automotive in-vehicle infotainment and vertical application devices (for restaurants, payments, et al.). For more information, visit the company's website at www.borqs.com.
Boxlight Corp. (BOXL)
Boxlight (NASDAQ: BOXL) is a provider of technology and STEM solutions for the global education market. The company improves student engagement and learning outcomes by providing educators the products they need for the 21st Century classroom. The company develops, sells and services its integrated, interactive solution suite of software, classroom technologies, professional development, and support services. Boxlight also provides educators with thousands of free lesson plans and activities via MimioConnect®, an interactive teaching community. For more information, visit the company's website at www.boxlight.com.
Broadwind Energy Inc. (BWEN)
Broadwind Energy (NASDAQ: BWEN) is a precision manufacturer of structures, equipment and components for clean tech and other specialized applications. From gears and gearing systems for wind, oil and gas and mining applications to wind towers and industrial weldments, Broadwind has solutions for the clean tech, energy and infrastructure needs of the future. With facilities throughout the U.S., the Broadwind Energy team is committed to helping customers maximize performance of their investments—quicker, easier and smarter. For more information, visit the company's website at www.bwen.com.
Cannabics Pharmaceuticals Inc. (CNBX)
Cannabics Pharmaceuticals (OTC: CNBX) is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based cancer therapies that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer. For more information, visit the company's website at www.cannabics.com.
CannTrust Holdings (TSX: TRST) (OTCPK: CNTTF) is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings more than 40 years of pharmaceutical and healthcare experience to the medical cannabis industry and serves over 57,000 medical patients with its dried, extract and capsule products. The company operates its 450,000-square-foot Niagara Perpetual Harvest Facility. The industry's broadest product portfolio is prepared and packaged at the 60,000-square-foot manufacturing center of excellence in Vaughan, Ontario. CannTrust is also developing nanotechnology to develop new products in the medical, recreational, beauty, wellness and pet markets. For more information, visit the company's website at www.canntrust.ca.
Canopy Growth (TSX: WEED) (NYSE: CGC) is a diversified cannabis and hemp company offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Canopy Growth offers the world's only medically approved vaporizers through the company's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a commitment to building a world-class cannabis company one product, site and country at a time. The company has operations in 15 countries across five continents. For more information, visit the company's website at www.canopygrowth.com.
Capstone Turbine Corp. (CPST)
Capstone Turbine (NASDAQ: CPST) produces low-emission microturbine systems and was the first to market commercially viable microturbine energy products. Capstone Microturbine award-winning systems have logged millions of documented runtime operating hours worldwide. Capstone is a member of the U.S. Environmental Protection Agency's Combined Heat and Power Partnership, which is committed to improving the efficiency of the nation's energy infrastructure and reducing emissions of pollutants and greenhouse gases. Capstone is a DQS-Certified ISO 9001:2015 and ISO 14001:2015 certified company with sales and/or service centers in the United States, Latin America, Europe, Middle East and Asia. For more information, visit the company's website at www.capstoneturbine.com.
Carriage Services Inc. (CSV)
Carriage Services (NYSE: CSV) is a U.S. provider of funeral and cemetery services and merchandise. Carriage operates 182 funeral homes in 29 states and 32 cemeteries in 11 states. For more information, visit the company's website at www.carriageservices.com.
Castle Brands Inc. (ROX)
Castle Brands (NYSE: ROX) is a developer and international marketer of premium and super-premium brands including: Jefferson's, Jefferson's Presidential Select, Jefferson's Reserve, Jefferson's Ocean Aged at Sea Bourbon, Jefferson's Wine Finish Collection and Jefferson's Wood Experiments, Goslings Rums, Goslings Stormy Ginger Beer, Knappogue Castle Whiskey, Clontarf Irish Whiskey, Pallini Limoncello, Boru Vodka, Brady's Irish Cream, The Arran Malt Single Malt Scotch Whisky, The Robert Burns Scotch Whisky and Machrie Moor Scotch Whisky. For more information, visit the company's website at www.castlebrandsinc.com.
Catasys Inc. (CATS)
Catasys (NASDAQ: CATS) harnesses proprietary big data predictive analytics, artificial intelligence and telehealth combined with human intervention to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. The company's mission is to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions. Catasys' OnTrak solution is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions. OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. For more information, visit the company's website at www.catasys.com.
CECO Environmental Corp. (CECE)
CECO Environmental (NASDAQ: CECE) is a global leader in air quality and fluid handling serving the energy, industrial and other niche markets. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean and more efficient solutions that help protect shared environments. CECO works to improve air quality, optimize the energy value chain, and provide custom engineered solutions for applications including oil and gas, power generation, water and wastewater, battery production, poly silicon fabrication, chemical and petrochemical processing along with a range of others. For more information, visit the company's website at www.cecoenviro.com.
Celsius Holdings Inc. (CELH)
Celsius Holdings (NASDAQ: CELH) has a branded portfolio of beverage lines, each offering proprietary, functional, healthy-energy formulas that are clinically proven to offer significant health benefits to its users. CELSIUS' functional claims are backed by six published studies in peer-reviewed journals. CELSIUS has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS line of products is Certified Kosher and Vegan. CELSIUS is also soy and gluten-free and contains very little sodium. CELSIUS is sold nationally through dominant fitness channel distributors and retailers. For more information, visit the company's website at www.celsius.com.
Century Casinos Inc. (CNTY)
Century Casinos (NASDAQ: CNTY) is an international casino entertainment company that operates worldwide. The company owns and operates Century Casino & Hotels in Cripple Creek and Central City, Colorado, and in Edmonton, Alberta, Canada; and the Century Casino in Calgary and St. Albert, Alberta, Canada and in Bath, England. Through its Austrian subsidiary, Century Resorts Management (CRM) GmbH, the company holds a 66.6% ownership interest in Casinos Poland Ltd., the owner of eight casino licenses throughout Poland. The company also operates 11 ship-based casinos under agreements with three cruise ship owners and continues to pursue other international projects in various stages of development. For more information, visit the company's website at www.cnty.com.
CEVA Inc. (CEVA)
CEVA (NASDAQ: CEVA) is a licensor of signal processing platforms and artificial intelligence processors for a smarter, connected world. CEVA partners with semiconductor companies and OEMs worldwide to create power-efficient, intelligent and connected devices for a range of end markets, including mobile, consumer, automotive, industrial and IoT. CEVA's ultra-low-power IPs for vision, audio, communications and connectivity include comprehensive DSP-based platforms for LTE/LTE-A/5G baseband processing in handsets, infrastructure and cellular IoT (NB-IoT and Cat-M1) enabled devices, advanced imaging and computer vision for any camera-enabled device, audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets. For more information, visit the company's website at www.ceva-dsp.com.
Chaparral Energy Inc. (CHAP)
Chaparral Energy (NYSE: CHAP) is an independent oil and natural gas exploration and production company headquartered in Oklahoma City. Founded in 1988, Chaparral is a pure-play operator focused on Oklahoma's highly economic STACK Play, where it has approximately 127,000 net acres primarily in Kingfisher, Canadian and Garfield counties. The company has approximately 265,000 net surface acres in the Mid-Continent region. For more information, visit the company's website at www.chaparralenergy.com.
Charles and Colvard (CTHR)
Charles & Colvard (NASDAQ: CTHR) is an e-commerce-driven business that uses innovative technology and sustainable practices to lead a revolution in the jewelry industry. As the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide, Charles & Colvard delivers a brilliant product at a revolutionary value that meets the needs of today's discerning customer. Jewelry consumers seek Charles & Colvard products because of their exceptional quality as well as their environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in the Research Triangle Park, North Carolina. For more information, visit the company's website at www.charlesandcolvard.com.
Charlotte's Web Holdings (CSE: CWEB) (OTCQX: CWBHF) is a market leader in the production and distribution of innovative hemp-based cannabidiol ("CBD") wellness products. The company's premium products start with proprietary hemp genetics that are responsibly manufactured into whole-plant hemp extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Charlotte's Web product categories include CBD Oil tinctures, CBD capsules, CBD topicals, as well as CBD pet products. Charlotte's Web hemp-based whole plant extracts are sold through select distributors, brick and mortar retailers, and online. For more information, visit the company's website at www.cwhemp.com.
Cherokee Inc. (CHKE)
Cherokee (NASDAQ: CHKE) is a global brand marketing organization that manages a growing portfolio of fashion and lifestyle brands, including Cherokee, TONY HAWK Signature Apparel and Hawk Brands, Liz Lange, Everyday California, Sideout, Hi-Tec, Magnum, 50 Peaks and Interceptor across multiple consumer product categories and retail tiers around the world. The company currently maintains license and franchise agreements with leading retailers and manufacturers that span over 110 countries in 12,000 retail locations and digital commerce. For more information, visit the company's website at www.cherokeeglobalbrands.com.
Chiasma Inc. (CHMA)
Chiasma (NASDAQ: CHMA) is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Employing its Transient Permeability Enhancer (TPE) technology platform, Chiasma seeks to develop and ultimately commercialize oral medications that are currently only available as injections. The company is developing octreotide capsules (conditionally trade named Mycapssa) for the potential maintenance therapy of adult patients with acromegaly in whom prior treatment with somatostatin analogs has been shown to be effective and tolerated. For more information, visit the company's website at www.chiasma.com.
China Online Education Group (COE)
China Online Education Group (NYSE: COE) is an online education platform in China with core expertise in English education. The company's mission is to make quality education accessible and affordable. The company's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students. For more information, visit the company's website at www.ir.51talk.com.
ChromaDex Corp. (CDXC)
ChromaDex (NASDAQ: CDXC) is a consumer-facing biotechnology company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world age better. For more information, visit the company's website at www.chromadex.com.
Cipherloc Corp. (CLOK)
CipherLoc (OTC: CLOK) is a data security solutions company and leading provider of highly-secure data protection technology whose vision is simple – Protect the World's Data. The company's innovative solutions are based on its patented Polymorphic Cipher Engine, which is designed to enable an ironclad layer of protection to be added to existing products, services, or applications. CipherLoc delivers solutions that are highly secure, synergistic, and scalable, keeping information safe in today's highly dangerous world. For more information, visit the company's website at www.cipherloc.net.
Citius Pharmaceuticals Inc. (CTXR)
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company's website at www.citiuspharma.com.
Clarus Corp. (CLAR)
Clarus (NASDAQ: CLAR) is focused on the outdoor and consumer industries, where it seeks opportunities to acquire and grow businesses that can generate attractive shareholder returns. The company has substantial net operating tax loss carryforwards which it is seeking to redeploy to maximize shareholder value. Clarus' primary business is as a leading developer, manufacturer and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport categories. The company's products are principally sold under the Black Diamond®, Sierra® and PIEPS® brand names through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and internationally. For more information, visit the company's website at www.claruscorp.com.
Clearfield Inc. (CLFD)
Clearfield (NASDAQ: CLFD) designs, manufactures and distributes fiber optic management, protection and delivery products for communications networks. The company's "fiber to anywhere" platform serves the unique requirements of leading incumbent local exchange carriers (traditional carriers), competitive local exchange carriers (alternative carriers), and MSO/cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center and military markets. Headquartered in Minneapolis, Minnesota, Clearfield deploys more than a million fiber ports each year. For more information, visit the company's website at www.SeeClearfield.com.
Codexis Inc. (CDXS)
Codexis (NASDAQ: CDXS) is a protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis' proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, visit the company's website at www.codexis.com.
Coeur Mining (CDE)
Coeur Mining (NYSE: CDE) is a well-diversified growing precious metals producer with five mines in North America. Coeur produces from its wholly owned operations: the Palmarejo silver-gold complex in Mexico, the Silvertip silver-zinc-lead mine in British Columbia, the Rochester silver-gold mine in Nevada, the Wharf gold mine in South Dakota, and the Kensington gold mine in Alaska. In addition, the company has interests in several precious metals exploration projects throughout North America. For more information, visit the company's website at www.coeur.com.
CohBar Inc. (CWBR)
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company focused on the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. MBTs originate from the discovery by CohBar's founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar's efforts focus on the development of these mitochondrial-derived peptides (MDPs) into clinically relevant MBTs that offer the potential to address a broad range of age-related diseases with underlying metabolic dysfunction. For more information, visit the company's website at www.cohbar.com.
Columbus McKinnon Corp. (CMCO)
Columbus McKinnon (NASDAQ: CMCO) is a worldwide designer, manufacturer and marketer of motion control products, technologies, systems and services that efficiently and ergonomically move, lift, position and secure materials. Key products include hoists, actuators, rigging tools, light rail work stations and digital power and motion control systems. The company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how. For more information, visit the company's website at www.cmworks.com.
Compass Diversified Holdings (CODI)
Compass Diversified Holdings (NYSE: CODI) owns and manages a diverse family of established North American middle market businesses. Each of its current subsidiaries is a leader in its niche market. CODI maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. The company provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility. CODI utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the company and to make cash distributions to its shareholders. For more information, visit the company's website at www.compassdiversifiedholdings.com.
Conatus Pharmaceuticals Inc. (CNAT)
Conatus Pharmaceuticals Inc.(NASDAQ: CNAT) is a biotechnology company focused on the development of novel medicines to treat liver disease. In collaboration with Novartis, Conatus is developing its lead compound, emricasan, for the treatment of patients with chronic liver disease. Emricasan is a first-in-class, orally active pan-caspase inhibitor designed to reduce the activity of enzymes that mediate inflammation and apoptosis. Conatus believes that by reducing the activity of these enzymes, caspase inhibitors have the potential to interrupt the progression of a variety of diseases. For more information, visit the company's website at www.conatuspharma.com.
Consolidated Water Co. Ltd. (CWCO)
Consolidated Water (NASDAQ: CWCO) develops and operates seawater desalination plants and water distribution systems in areas of the world where naturally occurring supplies of potable water are scarce. The company operates water production and/or distribution facilities in the Cayman Islands, Belize, the British Virgin Islands, The Bahamas, and Bali, Indonesia. The company also manufactures and services a wide range of products and provides design, engineering, management, operating and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment in the United States. For more information, visit the company's website at www.cwco.com.
ContraVir Pharmaceuticals Inc. (CTRV)
ContraVir Pharmaceuticals (NASDAQ: CTRV) is a biopharmaceutical company focused on the development and commercialization of targeted therapies for liver disease arising from chronic hepatitis B, C and D virus (HBV, HVC, HDV) and non-alcoholic steatohepatitis (NASH). The company is developing two novel anti-HBV compounds with complementary mechanisms of action. TXL, a direct acting antiviral (DAA) nucleotide analog lipid prodrug of tenofovir (TFV), is designed to deliver higher hepatic intracellular concentrations of the active tenofovir species (tenofovir diphosphate) while reducing concentrations of tenofovir outside the liver, causing fewer off-target toxicities and side-effects. CRV431, the other anti-HBV compound, is a host-targeting antiviral (HTA) next-generation cyclophilin inhibitor with a novel chemical structure that optimizes the selective index against HBV. For more information, visit the company's website at www.contravir.com.
Control4 Corp. (CTRL)
Control4 (NASDAQ: CTRL) is a global provider of automation and networking systems for homes and businesses, offering personalized control of lighting, music, video, comfort, security, communications and more into a unified smart home system. Control4 unlocks the potential of connected devices, making networks more robust, entertainment systems easier to use, homes more comfortable and energy efficient. The Control4 platform interoperates with more than 12,500 third-party consumer electronics products, ensuring an ever-expanding ecosystem of devices will work together - delivering intelligent solutions for consumers, major consumer electronics companies, hotels and businesses around the world. For more information, visit the company's website at www.control4.com.
Convectium (OTC: JKSM), a Jacksam Corporation company, is the creator of the first wax & oil disposable for the vaping industry, one of the first dry herb vaporizers, and the industry's first American-designed filling machine. Using our 710Shark oil filling machine and 710Captain capping machine, customers are able to fill and cap 100 cartridges in under a minute- increasing their output by 60x! Our line entire line of U.S. engineered, proprietary hardware and infrastructure is focused on automation and quality. For more information, visit the company's website at www.convectium.com.
Cooper-Standard Holdings Inc. (CPS)
Cooper-Standard Holdings (NYSE: CPS) is a global supplier of systems and components for the automotive industry. The Michigan-based company's products include rubber and plastic sealing, fuel and brake lines, fluid transfer hoses and anti-vibration systems. Cooper Standard employs approximately 33,000 people globally and operates in 21 countries around the world. For more information, visit the company's website at www.cooperstandard.com.
CorMedix Inc. (CRMD)
CorMedix (NYSE: CRMD) is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is developing its lead product Neutrolin, a novel non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. Neutrolin is currently in phase 3 development for patients undergoing chronic hemodialysis. Neutrolin has FDA Fast Track status and is already marketed as a CE Marked product in Europe and other territories. For more information, visit the company's website at www.cormedix.com.
Corvus Gold Inc. (CORVF)
Corvus Gold (OTC: CORVF) is a North American gold exploration and development company focused on its near-term gold-silver mining project at the North Bullfrog and Mother Lode Districts in Nevada. In addition, the company controls a number of royalties on other North American exploration properties representing a spectrum of gold, silver and copper projects. Corvus is committed to building shareholder value through new discoveries and the expansion of its projects to maximize share price leverage in an advancing gold and silver market. For more information, visit the company's website at www.corvusgold.com.
Cosmos Holdings (COSM)
Cosmos Holdings (OTC: COSM) is a fully reporting pharmaceutical holding company based in Chicago, Illinois, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe. The company is focused on identifying, acquiring, developing and commercializing different medicines to improve patients' lives. Cosmos has a large network of over 160 clients and vendors in Germany, United Kingdom, United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, Netherlands and Greece, with offices and distribution centers in Thessaloniki, Greece and in Harlow, UK. For more information, visit the company's website at www.cosmosholdingsinc.com.
CPS Technologies Corp. (CPSH)
CPS Technologies (NASADAQ: CPSH) is a global leader in producing metal-matrix composite components used to improve the reliability and performance of various electrical systems. CPS products are used in motor controllers for hybrid and electric vehicles, high-speed trains, subway cars and wind turbines. They are also used as heatspreaders in internet switches, routers and high-performance microprocessors. CPS also develops and produces metal-matrix composite armor. For more information, visit the company's website at www.alsic.com.
Cresco Labs (CSE: CL) (CRLBF) is a U.S. cannabis company with experienced management, access to capital, and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco's products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles. For more information, visit the company's website at www.crescolabs.com.
Crocs Inc. (CROX)
Crocs (NASDAQ: CROX) is a world leader in innovative casual footwear for women, men and children, combining comfort and style with a value that consumers know and love. Every pair of shoes within Crocs' collection contains Croslite material, a proprietary, molded footwear technology, delivering extraordinary comfort with each step. Crocs believes that expressing yourself and being comfortable are not mutually exclusive. For more information, visit the company's website at www.crocs.com.
Crown Crafts Inc. (CRWS)
Crown Crafts (NASDAQ: CRWS) designs, markets and distributes infant, toddler and juvenile consumer products and is one of America's largest producers of infant bedding, toddler bedding, bibs and developmental toys. The company operates through its three wholly owned subsidiaries: NoJo Baby & Kids Inc., Sassy Baby Inc. and Carousel Designs LLC. The company's subsidiaries market a variety of infant, toddler and juvenile products under company-owned trademarks, as well as licensed collections and exclusive private label programs. Sales are made directly to retailers such as mass merchants, large chain stores and juvenile specialty stores, as well as directly to consumers online. For more information, visit the company's website at www.crowncrafts.com.
Cryoport Inc. (CYRX)
Cryoport (NASDAQ: CYRX) is a global provider of solutions for maintaining temperature-sensitive life sciences commodities during distribution. The company serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. Cryoport's solutions are used by points-of-care, CROs, central laboratories, pharmaceutical companies, manufacturers and university researchers as well as the reproductive medicine market and the animal health market. Cryoport's proprietary Cryoport Express Shippers, Cryoportal Logistics Management Platform, leading-edge SmartPak II Condition Monitoring System and geo-sensing technology help make Cryoport a trusted end-to-end cold chain logistics partner. For more information, visit the company's website at www.cryoport.com.
Curaleaf (CSE: CURA) (OTCPK: CURLF) is a vertically integrated cannabis operator in the United States. The company has a presence in 12 states, and owns and operates 29 dispensaries, 12 cultivation sites and nine processing sites with a focus on highly populated, limited license states. Curaleaf leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf's Florida operations were the first in the cannabis industry to receive the Safe Quality Food certification under the Global Food Safety Initiative. For more information, visit the company's website at www.curaleaf.com.
CV Sciences Inc. (CVSI)
CV Sciences (OTC: CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD. The company's Plus CBD Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences has primary offices and facilities in San Diego, California, and Las Vegas, Nevada. For more information, visit the company's website at www.cvsciences.com.
Cyclacel Pharmaceuticals Inc. (CYCC)
Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company using its expertise in cell cycle, transcriptional regulation and DNA damage response biology in cancer cells to develop innovative medicines. The transcriptional regulation program is evaluating CYC065, a CDK inhibitor, in patients with advanced solid cancers and in combination with venetoclax in patients with advanced hematological malignancies. The DNA damage response program is evaluating a combination of sapacitabine and seliciclib, a CDK inhibitor, in BRCA positive patients with advanced solid cancers and sapacitabine and olaparib, a PARP inhibitor, in BRCA positive patients with breast cancer. For more information, visit the company's website at www.cyclacel.com.
CymaBay Therapeutics Inc. (CBAY)
CymaBay Therapeutics (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with nonalcoholic steatohepatitis (NASH). Two phase 2 studies of seladelpar established proof-of-concept in PBC. CymaBay is currently conducting a phase 3 study of seladelpar for PBC and a phase 2b study of seladelpar for NASH. For more information, visit the company's website at www.cymabay.com.
CynergisTek Inc. (CTEK)
CynergisTek (NYSE: CTEK) is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve security, privacy, compliance, and document output goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services. For more information, visit the company's website at www.cynergistek.com.
Cypress Semiconductor Corp. (CY)
Cypress Semiconductor (NASDAQ: CY) provides advanced embedded solutions for the world's most innovative automotive, industrial, smart home appliances, consumer electronics and medical products. Cypress' microcontrollers, wireless and USB-based connectivity solutions, analog ICs, and reliable, high-performance memories help engineers design differentiated products and get them to market first. Cypress is committed to providing customers with the best support and development resources on the planet enabling them to disrupt markets by creating new product categories in record time. For more information, visit the company's website at www.cypress.com.
Cytori Therapeutics Inc. (CYTX)
Cytori Therapeutics (NASDAQ: CYTX) is developing, manufacturing and commercializing nanoparticle-delivered oncology drugs and autologous adipose-derived regenerative cell (ADRC) therapies within its Nanomedicine and Cell Therapy franchises, respectively. Cytori Nanomedicine is focused on the liposomal encapsulation of anti-neoplastic chemotherapy agents, which may enable the effective delivery of the agents to target sites while reducing systemic toxicity. Cytori Cell Therapy, prepared within several hours with the proprietary Celution System and administered to the patient the same day, has been shown in preclinical and clinical studies to act principally by improving blood flow, modulating the immune system, and facilitating wound repair. For more information, visit the company's website at www.cytori.com.
Daqo New Energy Corp. (DQ)
Daqo New Energy (NYSE: DQ) is a manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the company is one of the world's lowest cost producers of high-purity polysilicon. Daqo's highly efficient and technically advanced manufacturing facility in Xinjiang, China, currently has an annual polysilicon production capacity of 30,000 metric tons, and the company is undergoing a debottlenecking project and a capacity expansion project and expects to increase its annual polysilicon production capacity to 70,000 metric tons in the first quarter of 2020. For more information, visit the company's website at www.dqsolar.com.
Dare Bioscience Inc. (DARE)
Dare Bioscience (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's sexual health, vaginal health, fertility and contraception. The company's mission is to identify, develop and bring to market a portfolio of novel, differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women in these areas. Dare's product portfolio includes potential first-in-class candidates in clinical development: Ovaprene, a non-hormonal, monthly contraceptive vaginal ring; and Sildenafil Cream, a potential treatment for female sexual arousal disorder, as well as a proprietary solution-to-gel formulation of clindamycin to treat bacterial vaginosis via a single application. For more information, visit the company's website at www.darebioscience.com.
Darling Ingredients Inc. (DAR)
Darling Ingredients (NYSE: DAR) is a global developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a wide range of ingredients and specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy and fertilizer industries. With operations on five continents, the company collects and transforms all aspects of animal by-product streams into useable and specialty ingredients, such as gelatin, edible fats, feed-grade fats, animal proteins and meals, plasma, pet food ingredients, organic fertilizers, yellow grease, fuel feedstocks, green energy, natural casings and hides. For more information, visit the company's website at www.darlingii.com.
DASAN Zhone Solutions Inc. (DZSI)
DASAN Zhone Solutions (NASDAQ: DZSI) is a global provider of network access solutions for service providers and enterprise networks. The company provides a wide array of reliable, cost-effective networking technologies—including broadband access, mobile backhaul, Ethernet switching, Passive Optical LAN, and software-defined networks—to a diverse customer base that includes more than 1,000 of the world's most innovative network operators. DASAN Zhone Solutions is headquartered in Oakland, California, with operations in more than 20 countries worldwide. For more information, visit the company's website at www.dasanzhone.com.
Daxor Corp. (DXR)
Daxor (NYSE: DXR) is an innovative medical instrumentation and biotechnology company that manufactures the BVA-100 Blood Volume Analyzer, the only clinically available, rapid and accurate diagnostic to provide rapid direct measurement of a patient's blood volume. Daxor believes that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. The company's goal, working in conjunction with hospitals and clinics, is to achieve that possibility. Ultimately the company's mission is to help hospitals and physicians incorporate Daxor's BVA-100 diagnostic to significantly improve the quality of patient care. For more information, visit the company's website at www.daxor.com.
Delta Apparel Inc. (DLA)
Delta Apparel (NYSE: DLA) along with its operating subsidiaries, Salt Life LLC, M. J. Soffe LLC, and DTG2Go LLC, is an international design, marketing, manufacturing and sourcing company that features a diverse portfolio of lifestyle basic and branded activewear apparel, headwear and related accessories. The company specializes in selling casual and athletic products across distribution tiers, including specialty stores, boutiques, department stores, mid-tier and mass chains, and the U.S. military. The company's products are also made available direct-to-consumer on its websites (www.saltlife.com, www.coastapparel.com, www.soffe.com and www.deltaapparel.com). For more information, visit the company's website at www.deltaapparelinc.com.
Denison Mines Corp. (DNN)
Denison Mines (NYSE: DNN) is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. In addition to its 90% owned Wheeler River project, Denison's Athabasca Basin exploration portfolio consists of numerous projects covering approximately 320,000 hectares. Denison's interests also include a 22.5% ownership interest in the McClean Lake joint venture, which is currently processing ore from the Cigar Lake mine under a toll milling agreement, plus a 25.17% interest in the Midwest and Midwest A deposits, and a 65.92% interest in the J Zone and Huskie deposits on the Waterbury Lake property. For more information, visit the company's website at www.denisonmines.com.
Denny's Corp. (DENN)
Denny's (NASDAQ: DENN) is the franchisor and operator of one of America's largest franchised full-service restaurant chains, based on the number of restaurants. As of September 26, 2018, Denny's had 1,715 franchised, licensed, and company restaurants around the world, including 128 restaurants in Canada, Puerto Rico, Mexico, New Zealand, Honduras, the Philippines, Costa Rica, the United Arab Emirates, Guam, El Salvador, Guatemala and the United Kingdom. For more information, visit the company's website at www.dennys.com.
DHI Group Inc. (DHX)
DHI Group (NYSE: DHX) is a provider of data, insights and employment connections through specialized services for technology professionals and other select online communities. The company mission is to empower technology professionals and organizations that hire them to compete and win through expert insights and relevant employment connections. Employers and recruiters use DHI's websites and services to source, hire and connect with the most qualified and highly-skilled technology professionals, while professionals use our websites and services to find ideal employment opportunities, relevant job advice and tailored career-related data. DHI serves multiple markets in North America, Europe, the Middle East and the Asia Pacific region. For more information, visit the company's website at www.dhigroupinc.com.
Digi International Inc. (DGII)
Digi International (NASDAQ: DGII) is a global provider of business and mission-critical Internet of Things (IoT) connectivity products and services. The company helps customers create next-generation connected products and deploy and manage critical communications infrastructures in demanding environments with high levels of security, relentless reliability and bulletproof performance. Founded in 1985, Digi has helped customers connect over 100 million things, and growing. For more information, visit the company's website at www.digi.com.
Digital Ally Inc. (DGLY)
Digital Ally (NASDAQ: DGLY) specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets and consumer use. Digital Ally's complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide. For more information, visit the company's website at www.digitalallyinc.com.
Digital Turbine Inc. (APPS)
Digital Turbine (NASDAQ: APPS) connects top mobile operators, OEMs and publishers with app developers and advertisers worldwide. Its comprehensive Mobile Delivery Platform powers frictionless user acquisition and engagement, operational efficiency and monetization opportunities. Digital Turbine's technology platform has been adopted by more than 30 mobile operators and OEMs worldwide and has delivered more than one billion app preloads for tens of thousands advertising campaigns. The company is headquartered in Austin, Texas, with global offices in Durham, Mumbai, San Francisco, Singapore, Sydney and Tel Aviv. For more information, visit the company's website at www.digitalturbine.com.
DMC Global Inc. (BOOM)
DMC Global (NASDAQ: BOOM) operates in the oilfield products and services and industrial infrastructure sectors. The oilfield products and services sector is served by DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. The industrial infrastructure sector is served by DMC's NobelClad business, the world's largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. For more information, visit the company's website at www.dmcglobal.com.
Dthera Sciences (DTHR)
Dthera Sciences (OTC: DTHR) is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. Dthera is developing DTHR-ALZ, a medical device that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer's disease. To the company's knowledge, DTHR-ALZ is the first product to receive Breakthrough Device designation for the treatment of Alzheimer's disease, and Dthera Sciences is only the second digital therapeutic company to receive this designation. For more information, visit the company's website at www.dthera.com.
Duos Technologies Group Inc. (DUOT)
Duos Technologies Group (OTCQB: DUOT), through its wholly owned subsidiary, Duos Technologies Inc., provides advanced intelligent security and analytical technology solutions with a strong portfolio of intellectual property. The company's core competencies include intelligent technologies that combine machine learning, artificial intelligence and advanced video analytics that are delivered through its proprietary integrated enterprise command and control centraco® platform. The company provides its broad range of technology solutions with an emphasis on mission critical security, inspection and operations within the rail transportation, retail, petrochemical, government, and banking sectors. Duos Technologies also offers professional and consulting services for large data centers. For more information, visit the company's website at www.duostech.com.
Dyadic International Inc. (DYAI)
Dyadic International (OTC: DYAI) is a global biotechnology company developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1. The C1 microorganism, which enables the development and large-scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. For more information, visit the company's website at www.dyadic.com.
Earthstone Energy Inc. (ESTE)
Earthstone Energy (NYSE: ESTE) is a growth-oriented, independent energy company engaged in the acquisition, development and operation of oil and natural gas properties, primarily in the Midland Basin of West Texas. For more information, visit the company's website at www.earthstoneenergy.com.
Eastside Distilling Inc. (EAST)
Eastside Distilling (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits in Portland, Oregon, since 2008. The company is distinguished by its highly decorated product lineup that includes Burnside Bourbon, West End American Whiskey, Goose Hollow Reserve, Below Deck Rums, Portland Potato Vodka, Hue-Hue Coffee Rum and a distinctive line of fruit infused spirits. Eastside Distilling is majority owner of Big Bottom and the Redneck Riviera Whiskey Co. All Eastside, Big Bottom and Redneck Riviera spirits are crafted from natural ingredients for quality and taste. For more information, visit the company's website at www.eastsidedistilling.com.
Edison Nation Inc. (EDNT)
Edison Nation (NASDAQ: EDNT) is a vertically integrated innovation aggregation and full-service product development and manufacturing company, offering innovation sourcing, design, sales, fulfillment and shipping services. Edison Nation's model is to provide a risk mitigated platform that connects innovators with companies to bring new products to market. For more information, visit the company's website at www.edisonnation.com.
eGain Corp. (EGAN)
eGain (NASDAQ: EGAN) customer engagement solutions deliver digital transformation for leading brands – powered by virtual assistance, AI, knowledge and analytics. The company's comprehensive suite of applications help clients deliver memorable, digital-first customer experiences in an omnichannel world. For more information, visit the company's website at www.egain.com.
Eidos Therapeutics Inc. (EIDX)
Eidos Therapeutics (NASDAQ: EIDX) is a clinical-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Eidos is developing AG10, a potentially disease-modifying therapy for the treatment of ATTR. For more information, visit the company's website at www.eidostx.com.
Ekso Bionics Holdings Inc. (EKSO)
Ekso Bionics Holdings (NASDAQ: EKSO) develops exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. For more information, visit the company's website at www.eksobionics.com.
Eldorado Resorts Inc. (ERI)
Eldorado Resorts (NASDAQ: ERI) is a casino entertainment company that owns and operates 28 properties in 13 states, including Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Mississippi, Missouri, Nevada, New Jersey, Ohio, Pennsylvania and West Virginia. In aggregate, Eldorado's properties feature more than 30,000 slot machines and VLTs and 800 table games, and over 12,500 hotel rooms. For more information, visit the company's website at www.eldoradoresorts.com.
Electra Meccanica Vehicles Corp. (SOLO)
Electra Meccanica Vehicles (NASDAQ: SOLO) is a designer and manufacturer of electric vehicles. The company builds the innovative, all-electric SOLO, a single passenger vehicle developed to revolutionize the way people commute, and is developing the Tofino, an elegant high-performance two-seater electric roadster sports car. Both vehicles are designed for the ultimate driving experience while making commuting more efficient, cost-effective and environmentally friendly. Intermeccanica, a subsidiary of Electra Meccanica, has successfully been building high-end specialty cars for 59 years. The Electra Meccanica family aims to deliver next generation affordable electric vehicles to the masses. For more information, visit the company's website at www.electrameccanica.com.
Enanta Pharmaceuticals Inc. (ENTA)
Enanta Pharmaceuticals (NASDAQ: ENTA) is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Enanta's R&D efforts are currently focused on the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus (HBV). Enanta's research and development activities are currently funded by royalties from HCV products developed under its collaboration with AbbVie. For more information, visit the company's website at www.enanta.com.
Endeavour Silver Corp. (EXK)
Endeavour Silver (NYSE: EXK) is a mid-tier precious metals mining company that owns and operates three high-grade, underground, silver-gold mines in Mexico. Endeavour is currently commissioning its fourth mine at El Compas, advancing a possible fifth mine at the Terronera mine project and exploring its portfolio of exploration and development projects in Mexico and Chile to facilitate its goal to become a premier senior silver producer. For more information, visit the company's website at www.edrsilver.com.
Energous Corp. (WATT)
Energous (NASDAQ: WATT) is leading the next generation of wireless charging with its award-winning WattUp technology, which supports fast, efficient contact-based charging, as well as charging over-the-air. WattUp is a scalable, RF-based wireless charging technology that offers substantial improvements in contact-based charging efficiency, foreign object detection, orientation freedom and thermal performance. The technology can be designed into many different sized electronic devices for home and office, as well as the medical, industrial, retail and automotive industries, ensuring interoperability across products. For more information, visit the company's website at www.Energous.com.
Energy Focus Inc. (EFOI)
Energy Focus (NASDAQ: EFOI) is an industry-leading innovator of energy-efficient LED lighting technology. As the creator of the first, and so far, only UL-verified low-flicker LED products on the U.S. market, Energy Focus products provide extensive energy and maintenance savings, and aesthetics, safety, health and sustainability benefits over conventional lighting. The company's customers include U.S. and foreign navies, U.S. federal, state and local government, healthcare and educational institutions, as well as Fortune 500 companies. For more information, visit the company's website at www.energyfocus.com.
Energy Fuels Inc. (UUUU)
Energy Fuels (NYSE: UUUU) is an integrated U.S. uranium mining company supplying U3O8 to major nuclear utilities. Energy Fuels holds three of America's key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch Processing Facility in Wyoming, and the Alta Mesa Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today and has a licensed capacity of over 8 million pounds of U3O8 per year. Energy Fuels also has the largest uranium resource portfolio in the U.S. among producers. Energy Fuels also produces vanadium as market conditions warrant. For more information, visit the company's website at www.energyfuels.com.
Enphase Energy Inc. (ENPH)
Enphase Energy (NASDAQ: ENPH) is a global energy technology company that delivers smart, easy-to-use solutions that connect solar generation, storage and management on one intelligent platform. The company revolutionized solar with its microinverter technology and produces the world's only truly integrated solar plus storage solution. Enphase has shipped more than 18 million microinverters, and over 820,000 Enphase systems have been deployed in more than 120 countries. For more information, visit the company's website at www.enphase.com.
ENSERVCO Corp. (ENSV)
ENSERVCO (NYSE: ENSV), through its various operating subsidiaries, provides a wide range of oilfield services, including hot oiling, acidizing, frac water heating, water transfer and related services. The company has a broad geographic footprint covering seven major domestic oil and gas basins and serves customers in Colorado, Montana, New Mexico, North Dakota, Oklahoma, Pennsylvania, Ohio, Texas, Wyoming and West Virginia. For more information, visit the company's website at www.enservco.com.
Enviroleach (CSE: ETI) (OTC: EVLLF) is a technology company and near-term gold producer that is engaged in the development and commercialization of environmentally-friendly formulas and technologies for the treatment of materials in the mining and E-Waste sectors. Using its proprietary non-cyanide non-acid based process, EnviroLeach extracts precious and base metals from ores, concentrates, and E-Waste using only FDA approved additives. For more information, visit the company's website at www.enviroleach.com.
Escalade Inc. (ESCA)
Escalade (NASDAQ: ESCA) is a quality manufacturer and distributor of sporting goods through its wholly owned subsidiary Escalade Sports. Escalade Sports manufactures, imports and distributes widely recognized sporting goods brands in basketball goals, archery, indoor and outdoor game recreation and fitness products through major sporting goods retailers, specialty dealers, key online retailers, traditional department stores and mass merchants. Escalade is a leader in table tennis tables, residential in-ground basketball goals and in archery bows. For more information, visit the company's website at www.escaladeinc.com.
ESSA Pharma Inc. (EPIX)
ESSA Pharma (NASDAQ: EPIX) is a pharmaceutical company focused on developing novel and proprietary therapies for the treatment of castration-resistant prostate cancer ("CRPC") in patients whose disease is progressing despite treatment with current therapies. ESSA believes that its proprietary compounds can significantly expand the interval of time in which patients suffering from CRPC can benefit from hormone-based therapies, by disrupting the androgen receptor ("AR") signaling pathway that drives prostate cancer growth and by preventing AR transcriptional activity by binding selectively to the N-terminal domain ("NTD") of the AR. A functional NTD is essential for transactivation of the AR. For more information, visit the company's website at www.essapharma.com.
EverQuote Inc. (EVER)
EverQuote (NASDAQ: EVER) operates an online insurance marketplace in the U.S., connecting consumers with insurance providers. The company's data & technology platform matches and connects consumers seeking to purchase insurance with relevant options from the company's broad direct network of insurance providers, saving consumers and providers time and money. EverQuote was founded with the vision of applying a scientific, data-driven approach to help consumers find the best price and coverage for their individual insurance needs. For more information, visit the company's website at www.everquote.com.
Evofem Biosciences Inc. (EVFM)
Evofem Biosciences (NASDAQ: EVFM) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem is leveraging its proprietary Multipurpose Vaginal pH Regulator (MVP-R) gel to develop product candidates for multiple indications, including prevention of pregnancy, prevention of urogenital transmission of chlamydia and gonorrhea in women and the prevention of recurrent bacterial vaginosis. For more information, visit the company's website at www.evofem.com.
Evolution Petroleum Corp. (EPM)
Evolution Petroleum (NYSE: EPM) is an independent oil and gas company focused on delivering a sustainable dividend yield to its shareholders through the ownership, acquisition and management of producing oil and gas properties in the U.S. The company's long-term goal is to build a diversified portfolio of oil and gas assets primarily through acquisition, while seeking opportunities to maintain and increase production through selective development, production enhancement and other exploitation efforts on its properties. For more information, visit the company's website at www.EvolutionPetroleum.com.
Eyenovia Inc. (EYEN)
Eyenovia (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenovia's pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, glaucoma, mydriasis and other eye diseases. For more information, visit the company's website at www.eyenoviabio.com.